Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children
Condition(s):Fetal Alcohol Syndrome (FAS)Last Updated:August 30, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Fetal Alcohol Syndrome (FAS)Last Updated:August 30, 2019Completed
Condition(s):Colon CancerLast Updated:December 14, 2020Recruiting
Condition(s):EGCG Influence on Catecholamine MetabolismLast Updated:June 27, 2017Completed
Condition(s):Alzheimer’s DiseaseLast Updated:April 15, 2020Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:April 15, 2020Completed
Condition(s):Down Syndrome (DS)Last Updated:February 11, 2016Completed
Condition(s):Light Chain (AL) Amyloidosis; Cardiac InvolvementLast Updated:October 17, 2017Completed
Condition(s):Multiple SclerosisLast Updated:October 31, 2019Completed
Condition(s):Diabetes Mellitus; HyperlipidemiaLast Updated:May 26, 2014Unknown status
Condition(s):Huntington DiseaseLast Updated:June 16, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.